Skip to main content
Clinical Trials/NCT05049135
NCT05049135
Completed
Not Applicable

Long Distance Diagnostics of Sleep Apnea With Objective Sleep Data From a Sensor-less Monitor - a Feasibility Study

Helse Nord-Trøndelag HF1 site in 1 country65 target enrollmentSeptember 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obstructive Sleep Apnea
Sponsor
Helse Nord-Trøndelag HF
Enrollment
65
Locations
1
Primary Endpoint
Apnea/hypopnea index
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

To evaluate the feasibility of a sensor-less sleep monitor (Somnofy®) in diagnosis and follow-up in obstructive sleep apnea. The study will explore the monitor's usefulness in detection of apnea during sleep, and compare the data to standard diagnostic registrations.

Detailed Description

A single-center prospective feasibility study. The study device is Somnofy®, a sensor-less commercially available sleep monitor. The ability of the monitor to detect apneas or hypopneas based on ultra wideband radar technology will be evaluated. The Somnofy® radar data will be compared with the diagnostic data from the predicate polygraph device NOX-T3 and the OSAS event data from the Metronics AirView software from CPAP. Thus, it will be possible to assess if Somnofy® is able to detect the events registered from the diagnostic equipment. For patients started on Continous Positive Airway Pressure (CPAP) treatment, a new registration with Somnofy® will be performed 12 weeks after treatment initiation. The effect of obstructive sleep apnea on patient and partner reported outcomes before and after CPAP initiation will also be assessed through questionnaires and journals.

Registry
clinicaltrials.gov
Start Date
September 1, 2021
End Date
March 7, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • referred to the pulmonology department in the participating hospital (Sykehuset Levanger) with suspected sleep apnea
  • able to sign an informed consent

Exclusion Criteria

  • Pregnancy
  • Serious disease which could affect ability to complete the study
  • Complicated sleep disorders

Outcomes

Primary Outcomes

Apnea/hypopnea index

Time Frame: 72 hours

Apnea/hypopnea index defined as the number of apneas or hypopneas per hours of sleep

Secondary Outcomes

  • Sleep score(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials